Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Foster

Showing results (1061-1070 of 1,472) with videos related to

Pageof 148
Sort By:
Journal of Hepatology|August 11, 2012
Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statementMartin Schaefer, Lucile Capuron, Astrid Friebe, et al.
American Journal of Clinical Oncology|October 20, 2025
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian CancerAminah Jatoi, Nathan R Foster, Andrea Wahner Hendrickson, et al.
Archives of Toxicology|July 9, 2010
Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats following dietary exposure to ammonium perfluorooctanoate occurs through increased activation of the xenosensor nuclear receptors PPARα and CAR/PXRClifford R Elcombe, Barbara M Elcombe, John R Foster, et al.
Alimentary Pharmacology & Therapeutics|May 23, 2020
English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completedKathryn Drysdale, Yevedzo Ntuli, Jonathan Bestwick, et al.
Circulation|December 7, 2014
Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery diseaseViviany R Taqueti, Brendan M Everett, Venkatesh L Murthy, et al.
Circulation|July 27, 1999
Interactions between electronic article surveillance systems and implantable cardioverter-defibrillatorsW J Groh, S A Boschee, E D Engelstein, et al.
Journal of Gastrointestinal Cancer|November 22, 2008
Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943Steven R Alberts, Jonathan R Sande, Nathan R Foster, et al.
Hepatology (Baltimore, Md.)|February 5, 2002
Hepatitis C and cognitive impairment in a cohort of patients with mild liver diseaseDaniel M Forton, Howard C Thomas, Christine A Murphy, et al.
Clinical Imaging|May 3, 2016
Prostate cancer with a pseudocapsule at MR imaging: a marker of high grade and stage disease?Apurva A Bonde, Elena K Korngold, Bryan R Foster, et al.
Surgery|October 10, 2024
Is biochemical screening enough to guide calcium-sensing receptor gene mutational analysis when diagnosing familial hypocalciuric hypercalcemia? A retrospective studyAlexandros N Flaris, Taylor O Julsrud, Robert A Vierkant, et al.
Pageof 148

Showing results (1061-1070 of 1,472) with videos related to

Sort By:
Pageof 148
Journal of Hepatology|August 11, 2012
Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statementMartin Schaefer, Lucile Capuron, Astrid Friebe, et al.
American Journal of Clinical Oncology|October 20, 2025
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian CancerAminah Jatoi, Nathan R Foster, Andrea Wahner Hendrickson, et al.
Archives of Toxicology|July 9, 2010
Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats following dietary exposure to ammonium perfluorooctanoate occurs through increased activation of the xenosensor nuclear receptors PPARα and CAR/PXRClifford R Elcombe, Barbara M Elcombe, John R Foster, et al.
Alimentary Pharmacology & Therapeutics|May 23, 2020
English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completedKathryn Drysdale, Yevedzo Ntuli, Jonathan Bestwick, et al.
Circulation|December 7, 2014
Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery diseaseViviany R Taqueti, Brendan M Everett, Venkatesh L Murthy, et al.
Circulation|July 27, 1999
Interactions between electronic article surveillance systems and implantable cardioverter-defibrillatorsW J Groh, S A Boschee, E D Engelstein, et al.
Journal of Gastrointestinal Cancer|November 22, 2008
Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943Steven R Alberts, Jonathan R Sande, Nathan R Foster, et al.
Hepatology (Baltimore, Md.)|February 5, 2002
Hepatitis C and cognitive impairment in a cohort of patients with mild liver diseaseDaniel M Forton, Howard C Thomas, Christine A Murphy, et al.
Clinical Imaging|May 3, 2016
Prostate cancer with a pseudocapsule at MR imaging: a marker of high grade and stage disease?Apurva A Bonde, Elena K Korngold, Bryan R Foster, et al.
Surgery|October 10, 2024
Is biochemical screening enough to guide calcium-sensing receptor gene mutational analysis when diagnosing familial hypocalciuric hypercalcemia? A retrospective studyAlexandros N Flaris, Taylor O Julsrud, Robert A Vierkant, et al.
Pageof 148